Fanatrex

Manufacturer
California Pharmaceuticals LLC
Effective date
2015-11-19
Label type
HUMAN PRESCRIPTION DRUG LABEL
Version
5
Source
full-release
Hydrated at
2026-05-31 20:21:37

Label at a glance#

ProductFanatrex
Active ingredientGABAPENTIN
Label structure5 sections

Label contents#

Full prescribing information#

DESCRIPTION

DESCRIPTION SECTION

NDC 43093-105-01

Rx only

FusePaq™

FANATREX™

(gabapentin 25 mg/mL, in oral suspension - kit)



FusePaq™ kits provide a convenient approach to rapidly prepare prescription medications, as all components are pre-measured. This kit is manufactured according to US FDA current Good Manufacturing Practices (cGMP).


Description:


This kit contains active and inactive bulk materials to prepare 420 mL of a gabapentin oral suspension containing 25 mg/mL gabapentin.  This kit may only be used for the extemporaneous mixing of these ingredients by an appropriate licensed medical professional, in response to a physician's prescription, to create a medication tailored to the specialized needs of an individual patient.


Contents:

  • 10.5 g gabapentin, USP
  • 420 mL oral suspension vehicle (water, banana flavor, N-acetyl-D-glucosamine, strawberry flavor, marshmallow flavor, glycerin, stevia powder, acesulfame potassium, xanthan gum, monoammonium glycyrrhizinate, sodium saccharin, sodium benzoate, potassium sorbate, dibasic sodium phosphate)
  • Disposable funnel
  • Press-in bottle adaptor for oral dispenser
  • Oral dispenser
  • Instructions

SUGGESTED PREPARATION

SPL UNCLASSIFIED SECTION

Suggested Preparation
Gabapentin, 25 mg/mL oral suspension


1    Remove and Inspect the Contents of the Kit

Remove kit contents. Ensure that seals are present and intact on the gabapentin and oral suspension vehicle bottles. If the seals are not intact, do not use the kit.


2    Prepare for Mixing

Wear gloves and eye protection during mixing operations. Remove the seal from the oral suspension bottle. Break the seal and remove the cap from the gabapentin bottle.


3    Transfer Gabapentin to the Suspension Bottle

Uncap the suspension bottle. Using the included funnel, carefully transfer the gabapentin powder to the suspension bottle. Cap the suspension bottle and mix thoroughly by inverting and shaking until all contents are dissolved. Uncap the suspension bottle. Pour a small amount of the mixed suspension back into the gabapentin bottle. Cap the gabapentin bottle and shake to ensure that all residual gabapentin has been dissolved. Pour the liquid through the funnel into the suspension bottle. Discard the funnel and gabapentin powder bottle.


4    Complete the Mixing Process

Insert the press-in bottle adaptor into the suspension bottle. Recap the suspension bottle. Mix well by inverting repeatedly several times. Visually ensure that all contents are dissolved.


5    Re-label the Suspension

Label the mixed suspension as required for prescription products. Ensure that the original oral suspension vehicle label is removed or obscured, since the original label is no longer accurate once the suspension is prepared.

Store the unused kit at room temperature of 15-30°C (59-86°F). Once prepared, store the mixed suspension between 15-30°C (59-86°F). The mixed suspension is stable for at least eight weeks, based upon real-time and accelerated stability studies.

Each lot of suspension vehicle is tested to meet microbial limits per USP Microbial Limit Test <61>. In addition, the suspension vehicle formulation has passed the USP <51> Antimicrobial Effectiveness Test.

An oral dispenser is provided in the kit and may be used to facilitate delivery of the suspension.


U.S. Patents Pending


Manufactured by:
Fusion Pharmaceuticals, LLC
768 Calle Plano
Camarillo, CA 93012


CS75-A1 rev 0

DRUG BOTTLE LABEL

PACKAGE LABEL.PRINCIPAL DISPLAY PANEL

Do not use if safety seal is broken

Gabapentin
1-(Aminomethyl)cyclohexaneacetic acid
CAS #60142-96-3
CAUTION: For manufacturing, processing, repacking, or prescription compounding

Net contents: 10.5 g

Repackaged by Fusion Pharmaceuticals, LLC
Camarillo, CA 93012

CS73-A1 rev 0

Gabapentin LabelGabapentin Label

SUSPENSION BOTTLE LABEL

PACKAGE LABEL.PRINCIPAL DISPLAY PANEL

Do not use if safety seal is broken
For Prescription Compounding Only

Oral Suspension Vehicle
Dye and paraben free

Ingredients: water, banana flavor, N-acetyl-D-glucosamine, strawberry flavor, marshmallow flavor, glycerin, stevia powder, acesulfame potassium, xanthan gum, monoammonium glycyrrhizinate, sodium saccharin, potassium sorbate, sodium benzoate, dibasic sodium phosphate

Net Contents: 420 mL (14.2 fl oz)

Manufactured for:
Fusion Pharmaceuticals, LLC
Camarillo, CA 93012

CS74-A1 rev 0

Suspension LabelSuspension Label

Carton Box Label

PACKAGE LABEL.PRINCIPAL DISPLAY PANEL

Do not use if safety seal is broken

NDC 43093-105-01

Rx only

FusePaq™  Kit for Oral Suspension
Fanatrex™
(gabapentin 25 mg/mL, in oral suspension - kit)


Description:

This kit contains active and inactive bulk materials to prepare 420 mL of a gabapentin oral suspension containing 25 mg/mL gabapentin. This kit may only be used for the extemporaneous mixing of these ingredients by an appropriate licensed medical professional, in response to a physician's prescription, to create a medication tailored to the specialized needs of an individual patient.

Active Ingredient:

  • 10.5 g gabapentin, USP


Inactive Ingredients:

  • 420 mL oral suspension vehicle (water, banana flavor, N-acetyl-D-glucosamine, strawberry flavor, marshmallow flavor, glycerin, stevia powder, acesulfame potassium, xanthan gum, monoammonium glycyrrhizinate, sodium saccharin, potassium sorbate, sodium benzoate, dibasic sodium phosphate)
  • Disposable funnel
  • Press-in bottle adaptor for oral dispenser
  • Oral dispenser
  • Instructions


CAUTION: For manufacturing, processing, repacking, or presciption compounding. Federal law prohibits dispensing without prescription.

U.S. Patents Pending

CS72-A1 rev 0

Fanatrex BoxFanatrex Box

DailyMed Pharmacologic Classes#

Class, Version, Type table
ClassVersionTypeEffective
GABAPENTIN Pharmacologic Class Indexing4Indexing - Pharmacologic Class20230427

DailyMed Product Concepts#

Product concept, Relation, Version table
Product conceptRelationVersionEffective
cdc2ae60-922e-452d-a42f-787fe4e2ed06Product name120250123
7059096a-4b9f-36c2-db50-bb5c723e6e9eProduct name220250114
fa3f0129-3502-889f-f424-3a37727959e7Product name920181206
77d89e4c-f57f-326d-d7aa-787f8eebbd2bProduct name120140508

FDA-Initiated Inactive NDC Indexing#

NDC, Effective, Action table
NDCEffectiveActionDocumentIndexing SPLRelated label
43093-105-012020-01-31C16284748780-19d75b9d0-802c-f424-e053-dadaa90a57ceFANATREX

DailyMed Package Descriptions#

Package NDC, Product, Description table
Package NDCProductDescriptionFormQuantityStrengthSPL version
43093-105-01Fanatrex1 in 1 KITKIT15

DailyMed Dashboard NDC Coverage#

NDC, Dashboard title, SPL version table
NDCDashboard titleSPL versionValidationDashboard ZIP
43093-105FANATREX (GABAPENTIN) KIT [CALIFORNIA PHARMACEUTICALS LLC]5Legacy NDC, 1 package rows20151204_8c3ce84f-336b-4e8e-9593-81baec57ec46.zip

DailyMed Billing Units#

Package NDC, Billing unit, Product NDC table
Package NDCBilling unitProduct NDCDailyMed indexing SPLSPL versionEffective
43093-105-01ML - Milliliter43093-105a797b997-775c-42ae-a1a3-784c87a04e5f12015-10-02
38779-2461-1GM - Gram38779-246171d4449d-5b81-4727-8794-1bff81dfc0ea12013-02-19
38779-2461-2GM - Gram38779-24616ec83fd7-2a0c-42ca-a043-836ea171008912013-02-19
38779-2461-3GM - Gram38779-246112f6bf1a-3422-4375-ab63-e9403a25cb8a12013-08-02
38779-2461-4GM - Gram38779-2461b50bb803-277b-4214-addc-e4212679c56812013-02-19
38779-2461-5GM - Gram38779-2461fc6005ab-2546-40f5-8f55-5d41d40ba52a12013-02-19
38779-2461-7GM - Gram38779-24614e6ff1e5-a7ef-4390-a8f5-e9ab2ade60f412014-09-03
38779-2461-8GM - Gram38779-246182806a4d-a1ac-4890-9305-db31188600dc12013-02-19
38779-2461-9GM - Gram38779-2461dec3057d-d6e7-4322-bfb4-558ef55c25d912013-02-19

Products#

Every source-derived product name is available through these pages.

DailyMed product names page 1 of 1 · 18 matching rows.

NDC Codes#

Product NDC, Package NDC table
Product NDCPackage NDC
43093-10543093-105-01
38779-2461

Ingredients#

Every source-derived ingredient row is available through these pages.

DailyMed ingredient rows page 1 of 1 · 15 matching rows.

Source Document#

Source XML

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 1 matching rows.

Brand, Generic, Manufacturer table
BrandGenericManufacturerSPL set IDEffective dateAvailable safety fieldsJoin
24ea29f7-9f22-1bed-e054-00144ff8d46c8c3ce84f-336b-4e8e-9593-81baec57ec462015-11-19Exact identifier
spl id: 24ea29f7-9f22-1bed-e054-00144ff8d46c
spl set id: 8c3ce84f-336b-4e8e-9593-81baec57ec46

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.